A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...
Vous n'êtes pas connecté
Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class Indication expansion allows for the use of Furoscix in...
A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...
A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...
GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration...
GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration...
LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...
PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...